Alzheimer's & Dementia·7 AugPlasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's diseaseTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecEvaluating the Feasibility of a Personalized Endpoint in Down Syndrome‐associated Alzheimer’s Disease: Inventory‐facilitated Goal Attainment ScalingStudy in peopleBiomarkersPaper